Emotional blunting and cognitive profile in elderly depressed patients in treatment with vortioxetine

Introduction Antidepressants in older people have experienced their increase in medical prescriptions in recent decades whit comorbidity with other pathologies and drug polytherapies. With the use of antidepressants, can be observed side and unwanted effects (e.g. emotional blunting). Vortioxetine...

Full description

Bibliographic Details
Main Authors:	F. Franza, B. Solomita, A. Colucci, M. Perito, F. Pellegrino, G. Del Buono, G. Tavormina
Format:	Article
Language:	English
Published:	Cambridge University Press 2021-04-01
Series:	European Psychiatry
Subjects:	Depression EMOTIONAL BLUNTING Vortioxetine Pharmacology
Online Access:	https://www.cambridge.org/core/product/identifier/S0924933821008750/type/journal_article

Similar Items

Efficacy of vortioxetine monotherapy compared with combined therapy vortioxetine and olanzapine in the treatment of major depression – first results
by: Oppa M., et al.
Published: (2017-09-01)

Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population
by: Kato M, et al.
Published: (2023-11-01)

Experience with vortioxetine in the treatment of post-stroke depression
by: I. A. Strelnikova, et al.
Published: (2020-02-01)

DEPRESSION AND COGNITIVE DISTURBANCES: EXPERIENCE OF VORTIOXETINE USE IN NEUROLOGIC PRACTICE
by: Y. E. Azimova
Published: (2017-07-01)

The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease
by: I. V. Miliukhina
Published: (2020-10-01)

Efficiency and safety of Vortioxetine in the treatment of depressive disorders in cardiac patients
by: N. V. Filippova, et al.
Published: (2023-06-01)

Vortioxetine for depression treatment in hospital setting: experience from a single psychiatric hospital
by: O. V. Limankin, et al.
Published: (2020-10-01)

Vortioxetine usage in an elderly patient with major depressive disorder and accompanied by multiple physical conditions: A case report
by: Xiaoman Wang, et al.
Published: (2023-12-01)

Comparative efficacy and safety of escitalopram, desvenlafaxine, and vortioxetine in the acute treatment of anxious depression: A randomized rater-blinded, 6-week clinical trial
by: K.-S. Oh, et al.
Published: (2022-06-01)

The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
by: E. Papalexi, et al.
Published: (2021-04-01)

Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research
by: Djamila Bennabi, et al.
Published: (2019-11-01)

Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series
by: Marcin Siwek, et al.
Published: (2022-03-01)

Effects of Vortioxetine on Sleep Architecture of Adolescents with Major Depressive Disorder
by: Zuzana Mlyncekova, et al.
Published: (2023-10-01)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
by: Bing Cao, et al.
Published: (2019-01-01)

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine
by: Yoshimura R, et al.
Published: (2021-04-01)

Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report
by: Orkun Aydin, et al.
Published: (2018-01-01)

Effectiveness of vortioxetine for winter depression in bipolar disorder: A case report
by: Yusei Yamaguchi, et al.
Published: (2024-03-01)

Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
by: McIntyre RS, et al.
Published: (2021-02-01)

Review of a New Multimodal Antidepressant Vortioxetine
by: Oppa M, et al.
Published: (2016-08-01)

Effectiveness of vortioxetine in real-world clinical practice: Interim results from the relieve study
by: G. Mattingly, et al.
Published: (2021-04-01)

The Role of Vortioxetine in the Treatment of Depressive Symptoms in General Hospital Psychiatry: A Case-Series and PRISMA-Compliant Systematic Review of the Literature
by: Francesco Weiss, et al.
Published: (2024-01-01)

Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study
by: Diego Santos García, et al.
Published: (2022-10-01)

Emotional blunting in patients with depression. Part I: clinical characteristics
by: Michael Cronquist Christensen, et al.
Published: (2022-04-01)

Hypomanic switch during vortioxetine treatment: a case report
by: Efruz Pirdoğan Aydın, et al.
Published: (2019-01-01)

An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
by: Anish Shah, et al.
Published: (2018-05-01)

Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
by: Cristina Segura-Garcia, et al.
Published: (2021-03-01)

Effectiveness of vortioxetine in real-world clinical practice: Italian cohort results from the global RELIEVE study
by: S. De Filippis, et al.
Published: (2022-06-01)

Effectiveness of vortioxetine in real-world clinical practice: French cohort results from the global RELIEVE study
by: M. Polosan, et al.
Published: (2022-06-01)

Assessing emotional blunting in a psychiatric population: Psychometric properties of the Swedish version of the Oxford Depression Questionnaire
by: Elin Henriksson, et al.
Published: (2023-12-01)

Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults
by: Xinyan Zhang, et al.
Published: (2022-06-01)

The effectiveness of vortioxetine in patients with depression in real clinical practice
by: N. N. Petrova
Published: (2022-10-01)

The effect of vortioxetine on penicillin-induced epileptiform activity in rats
by: Muhammed Nur ÖGÜN, et al.

Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study
by: De Filippis S, et al.
Published: (2022-08-01)

Acneiform eruption associated with the use of vortioxetine
by: Rukiye Ay, et al.
Published: (2019-04-01)

Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study
by: Gregory Mattingly, et al.
Published: (2023-01-01)

Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine
by: Oppa M., et al.
Published: (2016-09-01)

Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study
by: Oleg A. Levada, et al.
Published: (2020-05-01)

Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
by: Inoue T, et al.
Published: (2021-12-01)

Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial
by: Giovanni Ostuzzi, et al.
Published: (2020-08-01)

Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study
by: Angel L. Montejo, et al.
Published: (2024-01-01)